The latest thought leadership from our expert teams

Active filters (1)
Whitepaper

The future of patient monitoring

1st Jul 2019

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

  • AI & Analytics
  • Connectivity & IoT
  • Digital health
  • Digital security
  • Digital service innovation
  • Human factors
  • Product realisation
  • Sensing
  • User Experience (UX)
Opinion

Pathology: time to join the digital world?

22nd Sep 2021

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

  • Digital health
  • Human factors
Webinar

Europe as an innovation powerhouse in ophthalmology

5th Aug 2021

Luis Diaz-Santana, Head of Ophthalmology at Cambridge Consultants, presented at OIS European Showcase virtual conference. Watch his presentation to hear his thoughts on if Europe really is an innovation powerhouse in ophthalmology.

  • Bioinnovation
  • Human factors
  • Physical sciences
Opinion

The insider’s view

2nd Aug 2021

What is it really like to work at Cambridge Consultants? Here, three senior colleagues look back on their time at the company and the experience of working here.

  • Digital service innovation
  • Embedded software
  • Human factors
  • Project management
  • Radio systems
Opinion

Our sustainable materials database is enabling innovation in the drive to net zero

10th Jun 2021

The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. I’m proud to be part of a team of colleagues dedicated to doing something about it – by creating a guide that is helping innovators switch to alternatives.

  • Bioinnovation
  • Innovation management
  • Product realisation
  • Sustainability
Opinion

Let’s go! The new Catapult consortium is a brilliant boost for cell and gene therapy manufacturing

8th Jun 2021

We’re thrilled to be a part of the CGT Catapult, working with 20 brilliant companies to accelerate the technology development for cell and gene therapy manufacturing. 

  • Bioinnovation
Opinion

Miniature active implants – the key area for innovation in next-generation drug delivery

2nd Jun 2021

Innovation in drug delivery devices has evolved at a constant pace for 30 years. But what's next? Our belief is that we sit on the cusp of a decade of innovation and commercial opportunity in active implants.

  • Digital health
  • Human factors
  • User Experience (UX)
Opinion

The challenge of scale down models

10th May 2021

Scale-down models have become a popular development tool, especially in the bioprocessing industry. But how do you make them robust and reproducible?

  • Bioinnovation
Opinion

Our core technology is at the heart of the world’s first FDA-approved fully at-home COVID-19 test

22nd Jan 2021

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

  • Bioinnovation
  • Digital health
  • Fluids & thermodynamics
  • Sensing
Webinar

The path to a sustainable future for inhalation products

17th Dec 2020

Dan Cowen, Senior Consultant at Cambridge Consultants, presented at Drug Delivery to the Lungs (DDL) - Christmas Lectures and talked about the path to a sustainable future for inhalation products. Watch his presentation to learn how sustainability in inhalation products can be achieved whilst maintaining safety and efficacy at the core.

  • Human factors
  • User Experience (UX)
Opinion

Medical device sustainability takes centre stage at DDL2020

16th Dec 2020

Sustainability emerged as a hot and emotive topic at this year’s Drug Delivery to the Lungs (DDL) conference, read Donal Taylor's thoughts on other key trends that emerged.

  • Human factors
  • Industrial design
  • Physical sciences
  • Product realisation
Opinion

It’s time to start removing the barriers to sustainability in personal drug delivery devices

9th Dec 2020

Matt Garwood challenges the medical device development status quo. If we embrace a bold, comprehensive response that begins at the concept stage and ends with the device user, it is possible to challenge conventional thinking and change for the better.  

  • Human factors
  • Industrial design
  • Physical sciences
  • Product realisation